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Abstract
Purpose Despite its high prognostic value, widespread clin-
ical implementation of 123I-meta-iodobenzylguanidine
(MIBG) myocardial scintigraphy is hampered by a lack of
validation and standardization. The purpose of this study
was to assess the reliability of planar 123I-MIBG myocardial
scintigraphy in patients with heart failure (HF).
Methods Planar myocardial MIBG images of 70 HF patients
were analysed by two experienced and one inexperienced
observer. The reproducibility of early and delayed heart-to-
mediastinum (H/M) ratios, as well as washout rate (WR)
calculated by two different methods, was assessed using the
intraclass correlation coefficient (ICC) and the Bland-Altman
analysis. In addition, a subanalysis in patients with a very low
H/M ratio (delayed H/M ratio <1.4) was performed. The
delayed H/M ratio was also assessed using fixed-size oval
and circular cardiac regions of interest (ROI).
Results Intra- and interobserver analyses and experienced
versus inexperienced observer analysis showed excellent
agreement for the measured early and delayed H/M ratios
and WR on planar 123I-MIBG images (the ICCs for the
delayed H/M ratios were 0.98, 0.96 and 0.90, respectively).
In addition, theWRwithout background correction resulted in
higher reliability than theWRwith background correction (the
interobserver Bland-Altman 95 % limits of agreement were
−2.50 to 2.16 and −10.10 to 10.14, respectively). Further-
more, the delayed H/M ratio measurements remained reliable
in a subgroup of patients with a very low delayed H/M ratio
(ICC 0.93 for the inter-observer analysis). Moreover, a fixed-
size cardiac ROI could be used for the assessment of delayed
H/M ratios, with good reliability of the measurement.
Conclusion The present study showed a high reliability of
planar 123I-MIBG myocardial scintigraphy in HF patients,
confirming that MIBG myocardial scintigraphy can be
implemented easily for clinical risk stratification in HF.
Keywords Heart failure . Planar MIBGmyocardial
scintigraphy . Delayed heart to mediastinum (H/M) ratio .
Region of interest (ROI) . Reproducibility
Introduction
The ageing of the population and the improved medical
treatment of cardiac patients has led to an increased preva-
lence of heart failure (HF) [1]. Despite the therapeutic
innovations, the mortality rate of patients with HF remains
high with an estimated 5-year mortality rate of 54 % in men
and 40 % in women [2].
Increased myocardial sympathetic activity is a prominent
feature of HF by which the failing heart tries to compensate
for the reduced cardiac output [3]. In the chronic state of HF
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these compensatory mechanisms become deleterious, caus-
ing myocardial hypertrophy and fibrosis, leading to cardiac
remodelling and restructuring [4]. At the cellular level, the
increased sympathetic activity causes increased neuronal
release of norepinephrine (NE), that leads to a significant
reduction in presynaptic NE uptake due to posttranscription-
al downregulation of the cardiac NE transporter [5]. The
decrease in the NE reuptake mechanism can be assessed
noninvasively by radionuclide imaging with the 123I-
labelled NE analogue meta-iodobenzylguanidine (MIBG)
[6]. MIBG is taken up into the presynaptic cardiac sympathet-
ic nerves by the NE uptake-1 transporter, and the amount of
MIBG retention over several hours after administration
reflects neuronal integrity [7]. The most commonly used
quantitative measurements of myocardial MIBG uptake are
the calculated heart-to-mediastinum (H/M) ratio and wash-
out ratio (WR) determined from planar MIBG images. A low
delayed H/M ratio has been shown to be an independent
predictor of ventricular tachyarrhythmia [8, 9], appropriate
ICD therapy [10] and sudden cardiac death [11] in HF
patients. In addition, an increased myocardial washout has
been associated with an adverse prognosis [12]. Subsequently,
planar MIBG myocardial scintigraphy has been demonstrated
to have strong prognostic value [13, 14].
Despite the proven prognostic value of MIBG imaging in
patients with HF, there are still several limitations that
prevent this technique from being implemented as a clinical
management tool in patients with HF [15]. Although almost
all reports include the H/M ratio and WR as the measure of
myocardial uptake, the methods used to obtain these param-
eters show substantial variation [16]. This variation can be
caused by the influence of collimator choice, acquisition
time and duration, and the location and size of the cardiac
and mediastinal regions of interest (ROIs) [17–19]. MIBG
uptake can be very low, particularly in patients with HF,
hampering the assessment of the cardiac ROI on planar
MIBG images. Therefore, the level of experience in drawing
the cardiac ROI on the planar MIBG images might influence
the measured H/M ratio and WR. Moreover, because of
this difficulty in determining the correct contours of the
cardiac ROI in HF patients, the assessment of the loca-
tion and size of the cardiac ROI might affect the mea-
sured H/M ratio and WR more in patients with HF as
compared to healthy subjects. Furthermore, different
methods are used to calculate the WR from early and
delayed planar MIBG images [16].
To our knowledge there are no studies that have com-
pared the use of these different mathematical methods for
the assessment of WR. Therefore, the effects of the method
on the clinical interpretation of WR remain unclear, and it is
uncertain which method would provide the more accurate
and reproducible estimates. Consequently, the reproducibil-
ity of the clinically important parameters of planar MIBG
myocardial scintigraphy remains unidentified in HF
patients. Therefore, the purpose of this study was to assess
the reproducibility of the H/M ratio and WR in HF patients.
We evaluated the influence of two different methods to
assess the WR, the effect of cardiac ROI size and position
on the assessment of the H/M ratio, as well as the impact of
the level of postprocessing experience on the reproducibility
of planar MIBG images.
Materials and methods
Study population
Patient data and MIBG myocardial scintigraphy images
collected as part of a previously reported clinical study were
utilized in the present analysis [10]. The study population
consisted of New York Heart Association (NYHA) func-
tional class III/IV HF patients with an impaired left ventricle
ejection fraction (LVEF) of ≤35 % who were clinically
referred for MIBG myocardial scintigraphy. All patients
were treated according to the ACC/AHA guidelines for the
diagnosis and management of HF [20], receiving optimal
pharmacological and revascularization therapy. From the
previously described patient population a random sample
of 70 HF patients was selected for the analysis of the current
study. The MIBG images of the selected patients were
reanalysed to evaluate the reproducibility of the H/M ratio
on the planar MIBG myocardial images.
MIBG data acquisition
Patient medication that could have influenced MIBG
myocardial uptake, predominantly antihypertensive drugs
and tricyclic antidepressants, were withdrawn. Patients
were pretreated with 120 mg of sodium iodide to block
uptake of free 123I by the thyroid gland. Sodium iodide
was given orally 1 h before intravenous administration of
185 MBq of MIBG (AdreView; GE Healthcare, Prince-
ton, NJ). MIBG planar imaging was performed with the
patient in the supine position. A 10-min planar anterior
thoracic image was acquired (256×256 matrix) 10–
15 min after tracer administration. Planar imaging was
repeated approximately 4 h after tracer administration
(delayed images). All camera heads were equipped with
low-energy high-resolution collimators and all images
were acquired with a 15 % energy window centred at
the 159 keV photopeak of 123I.
Planar MIBG image analysis
H/M ratios were calculated from planar MIBG images using a
ROI placed over the heart and over the upper mediastinum.
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Using dedicated postprocessing software on a Syngo-MI
workstation (Siemens Medical Solutions, Malvern, PA), the
cardiac ROI was assessed using a manually drawn polygonal
ROI placed over the myocardium including the left ventricular
cavity on the planar MIBG images (Fig. 1). The mediastinal
ROI with a rectangular shape was placed on the upper half of
the mediastinum and had a size of 13×20 pixels. The location
of the mediastinal ROI was determined using the following
anatomical landmarks: the lung apex as upper border, the
upper cardiac border and the medial contours of the lungs
(Fig. 1). The H/M ratio was computed by dividing the average
number of counts within the cardiac ROI by the average
number of counts within the mediastinal ROI. No background
correction was performed in this study.
The WR was calculated from early and delayed planar
images, using the two different methods as described in the
proposal for standardization by Flotats et al. [21]. In method 1
the following formula was used: WR0(He−H1)/He×100. In
method 2 the formula with background (BKG) correction was
used: WRBKG-corrected0[(He−Me)−(Hl−Ml)]/(He−Me)×100.
In these two formulas H represents the mean counts per pixel
in the cardiac ROI andM represents the mean counts per pixel
in the mediastinal ROI in the early (e) and delayed (l) planar
images. In this study, time decay was not corrected for in the
calculation of WR.
Reproducibility of H/M ratio on planar MIBG imaging
To assess the reproducibility of the measured H/M ratios
and WR, the intra- and interobserver agreements were
tested. Intraobserver variability was assessed by a single
reviewer (C.E.V.) who reviewed all planar MIBG images
twice, with at least 4 weeks between the first and the second
review to avoid recall bias. For the interobserver analysis two
reviewers (C.E.V. and M.J.B.) independently reviewed all
planar MIBG images. Both observers were experienced in
the analysis of MIBG myocardial scintigraphy. The reproduc-
ibility of the delayed H/M ratio measurements between an
experienced (C.E.V.) and an inexperienced observer (J.E.M.)
was also assessed. The inexperienced observer was given 2 h
of training in the postprocessing of planar MIBG images.
During this training, the postprocessing technique and the
exact location of the mediastinal ROI and cardiac ROI were
explained and five example cases were evaluated.
Subanalysis for reproducibility in patients
with a very low delayed H/M ratio
Because the reproducibility of planar MIBG imaging might
be different in patients with a very low delayed H/M ratio, a
subanalysis was performed including only patients with a
delayed H/M ratio of ≤1.4. The first measurements of one
experienced observer (C.E.V.) were used to divide the study
population into two groups: patients with a delayed H/M
ratio of ≤1.4 were included and patients with a delayed H/M
ratio of >1.4 were excluded. After selection of the patients
with a very low delayed H/M ratio, the reproducibility of the
delayed H/M ratio in this subpopulation was assessed by
intra- and interobserver analyses.
Image analysis using a manually drawn cardiac
ROI or a fixed-size cardiac ROI
An additional analysis was performed to assess the repro-
ducibility of the delayed H/M ratio using a fixed-size cardi-
ac ROI or a manually drawn ROI. In this analysis the
agreement between these two measurements was tested.
Two types of fixed-size cardiac ROI were used. First, an
oval cardiac ROI was placed over the myocardium includ-
ing the left ventricular cavity. The size of the oval ROI was
60×70 pixels (approximately 85×100 mm) and the long
axis of the oval was in line with the heart axis (Fig. 2a).
The second type of fixed-size cardiac ROI tested was circu-
lar with a predefined radius of 21 pixels (approximately
30 mm). The ROI was placed at the apex of the heart,
covering part of the myocardium and left ventricular cavity
(Fig. 2b). The mediastinal ROI was not changed in this
analysis and was determined as previously described and
depicted in Fig. 1.
Statistical analysis
All continuous variables are expressed as means ± SD.
Intraclass correlation coefficients (ICC) were calculated to
Fig. 1 The mediastinal ROI and the manually drawn polygonal cardi-
ac ROI on a planar MIBG image. The rectangular mediastinal ROI
(size 13×20 pixels) was placed in the upper half of the “anatomical
landmark square” formed by the lung apexes (upper square border), the
upper cardiac border (lower square border) and the medial contours of
the lungs (medial square borders). The manually drawn polygonal
cardiac ROI was placed over the myocardium including the left
ventricular cavity
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assess the reliability; a two-way mixed model was used with
statistical significance set at 95 %. Single measures are
reported for the intraobserver calculations and average
measures for the interobserver calculations. For clinically
relevant agreement the following criteria were used: ICC
values <0.49, 0.49–0.59, 0.60–0.74 and >0.74 were consid-
ered poor, fair, good and excellent, respectively. Bland-
Altman plots were used to evaluate the correlations between
the measured values. The sample size was calculated using
the method described by Shoukri et al. for the design of
reliability studies [22]. Furthermore, the ICC was assumed
to be at least 0.75. Accepting a 95 % confidence interval
(CI) width of the ICC of 0.20 70 patients was found to be
sufficient when measurements were performed by two in-
dependent observers. All statistical analyses were performed




A total of 70 randomly selected patients (64.5±8.7 years of
age, 53 (76 %) men) were included in the study. The
baseline characteristics of the patient population are shown
in Table 1. The mean NYHA functional class was 2.6±0.5,
and the mean LVEF was 26±7.4 % (Table 1). Of the 44
patients, 63 % had ischaemic cardiomyopathy. Medication
consisted of angiotensin-converting enzyme inhibitors or
angiotensin II antagonists (89 % of patients), beta-blockers
(70 % of patients), lipid-lowering agents (69 % of patients)
and diuretics (91 % of patients).
Reproducibility of planar MIBG imaging
The intra- and interobserver agreements, as well as the
agreement between experienced and inexperienced observ-
ers for the early and delayed H/M ratio and the WR are
summarized in Table 2. The interobserver analysis and the
experienced versus inexperienced observer analysis showed
small mean differences between the measured delayed H/M
Fig. 2 Oval and circular fixed-size cardiac ROIs on planar MIBG
images. a The oval cardiac ROI was placed over the myocardium
including the left ventricular cavity and had a size 60×70 pixels
(approximately 85×100 mm). The long axis of the oval was in line
with the heart axis. b The circular cardiac ROI had a predefined radius
of 21 pixels (approximately 30 mm) and was placed at the apex of the
heart, covering a part of the myocardium and left ventricular cavity.
Using the oval and circular cardiac ROIs, the calculated H/M ratios
were 1.45 and 1.43, respectively. In this patient the H/M ratio using the
polygonal manually drawn cardiac ROI was 1.46
Table 1 Characteristics of the study population (n070)
Characteristic Value
Gender (male), n (%) 53 (76)
Age (years, mean±SD) 64.5±8.7
Heart failure characteristics, n (%)
Ischaemic cardiomyopathy 44 (63)
Nonischaemic cardiomyopathy 26 (37)
NYHA functional class (mean±SD) 2.6±0.5
LVEF (%, mean±SD) 26±7.4




Family history of coronary artery diseasec 20 (29)
Current smoking 22 (31)






Lipid-lowering agent 48 (69)
Diuretic 64 (91)
a Serum total cholesterol ≥230 mg/dl and/or serum triglycerides
≥200 mg/dl or treatment with a lipid-lowering drug.
b Systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure
≥90 mm Hg and/or the use of antihypertensive medication.
c Presence of coronary artery disease in a first degree family member at
<55 years in men and <65 years in women
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ratios (Fig. 3). WR calculated from the early and delayed
planar images using method 1 was more reliable than that
calculated using method 2 (Table 2). This was confirmed by
the Bland-Altman analysis, which showed that WR calcu-
lated using method 2 had a wider range with larger mean
differences between measurements (Fig. 4).
Subanalysis for the reproducibility in patients with very low
delayed H/M ratio
In total, 37 patients (53 %) had a delayed H/M ratio of ≤1.4
and were selected for the subanalysis. The reproducibility of
the measured delayed H/M ratio remained excellent with an
ICC of 0.93 (95 % CI 0.85–0.96) and 0.93 (95 % CI 0.74–
0.97), for the intra- and interobserver analyses, respectively
(Table 3).
Fixed-size cardiac ROI
The H/M ratios measured using the oval cardiac ROI and
the circular cardiac ROI showed excellent agreement
compared to the ratios measured using a manually drawn
polygonal cardiac ROI, with ICCs of 0.95 (95 % CI
0.93–0.97) and 0.86 (95 % CI 0.72–0.93), respectively
(Table 4). The Bland-Altman analysis showed mean dif-
ferences in the H/M ratios of −0.002±0.063 for the oval
cardiac ROI (Fig. 5a, left) and −0.063±0.12 for the
circular cardiac ROI (Fig. 5b, left), and showed good
agreement between the mean counts measured in the oval
cardiac ROI and in the manually drawn cardiac ROI,
with 95 % limits of agreement of −1.19 to 0.95
(Fig. 5a, centre), but lower mean counts in the circular
cardiac ROI than in the manually drawn cardiac ROI,
with 95 % limits of agreement of −4.01 to 0.82 (Fig. 5b,
centre).
Discussion
The present study showed excellent reproducibility of the
assessment of the most reported clinical measurements on
planar MIBG images in HF patients. In particularly, when
using a manually drawn polygonal cardiac ROI the highest
level of agreement was observed between the measured H/M
ratios and WR. However, a fixed-size cardiac ROI can also be
used for the assessment of delayed H/M ratios, since high
agreement was seen between the measured delayed H/M
ratios obtained using a traditional manually drawn cardiac
ROI and those obtained using a fixed-size cardiac ROI. In
addition, for the calculation ofWR, the formula using only the
cardiac ROI from the early and delayed planar MIBG images
(WR0(He−H1)/He×100) provided more reliable values than
the formula including background correction. Excellent agree-
ment was also observed between the measurements of
the H/M ratios and WR performed by an experienced and an
inexperienced observer. A short period of training on the
postprocessing technique was enough to accurately assess
both the mediastinal ROI and the cardiac ROI, showing that
a limited amount of experience in combination with basic
anatomical knowledge is sufficient to successfully reproduce
the results of an experienced observer. Subsequently, the
results for the intra- and interobserver analyses could be
reproduced in a subpopulation of patients with a very
low H/M ratio, showing that the reproducibility remained
excellent over the total range of delayed H/M ratios. These
results imply that the measurements on planar MIBGmyocar-
dial scintigraphy are reliable even in patients with severe
myocardial sympathetic denervation patterns.
Several studies have shown the excellent prognostic value
of delayed H/M ratios and WR independent of other com-
monly used clinical parameters such as LVEF [12–14]. In
addition, patients with decreased delayed H/M or increased
Table 2 Agreements between
the measurements of the early
and delayed H/M ratios and WR
for the intra- and interobserver
analyses and the experienced
versus inexperienced observer
analysis
Early H/M ratio Delayed H/M ratio Washout rate (%)
Method 1 Method 2
Intraobserver analysis
First measurement 1.56±0.18 1.43±0.20 41.5±6.6 52.6±13.0
Second measurement 1.56±0.18 1.44±0.20 41.4±6.4 51.9±12.5
ICC (95 % CI) 0.99 (0.98–0.99) 0.98 (0.97–0.99) 0.99 (0.98–0.99) 0.94 (0.89–0.96)
Interobserver analysis
First observer 1.52±0.20 1.40±0.20 41.3±6.0 52.3±13.6
Second observer 1.56±0.18 1.44±0.20 41.4±6.4 52.6±13.0
ICC (95 % CI) 0.94 (0.70–0.98) 0.96 (0.76–0.98) 0.98 (0.96–0.99) 0.91 (0.85–0.94)
Experienced versus inexperienced observer analysis
Experienced observer 1.52±0.20 1.40±0.20 41.3±6.0 52.3±13.6
Inexperienced observer 1.54±0.17 1.45±0.19 41.1±6.5 49.5±13.6
ICC (95 % CI) 0.89 (0.81–0.94) 0.90 (0.70–0.95) 0.95 (0.92–0.97) 0.81 (0.70–0.88)
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myocardial MIBG washout show a higher risk of ventricular
arrhythmias and sudden cardiac death [8–11]. Therefore,
MIBG myocardial scintigraphy could assist in a more
individualized treatment strategy for HF patients. More-
over, changes in adrenergic cardiac activity in response
to pharmacological treatment in patients with HF can be
tracked with the use of MIBG imaging [23–25]. However,
even though multiple studies support the usefulness of this
technique, MIBG myocardial scintigraphy is not yet wide-
ly clinically implemented. One factor hampering the clin-
ical implementation of MIBG myocardial scintigraphy is
the lack of standardization of the acquisition and postpro-
cessing parameters [18]. Improved standardization of im-
aging protocols could contribute to increased applicability
of MIBG imaging in HF patients [16].
Although the H/M ratio obtained from planar images has
been used as a quantitative parameter in MIBG myocardial
scintigraphy, H/M ratios may vary markedly according to
the imaging equipment, especially with different types of
collimator [18, 26]. However, Nakajima et al. have recently
shown that standardization of H/M ratios by a heart chest
calibration phantom method is feasible among different
collimator types, allowing practical multicentre comparisons
of H/M ratios [27]. While the effect of collimator selection
on H/M ratios has been studied, similar attention should be
paid to the variation caused by differences in setting the
mediastinal and cardiac ROIs. Many independent reports
from centres in different continents have shown that MIBG
myocardial scintigraphy provides valuable prognostic infor-
mation. However, among these different investigations there
Fig. 3 Reproducibility of the
delayed H/M ratios determined
on planar MIBG images: a
intraobserver agreement (first




agreement. The mean difference
(95 % limits of agreement) in
the intraobserver analysis was
−0.008 (−0.079 to 0.064), in the
interobserver analysis was
−0.040 (−0.115 to 0.046), and
in the experienced versus
inexperienced observer analysis
was −0.053 (−0.199 to 0.094),
respectively
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is no consensus on the shape, size and positioning of the
ROIs for the heart and the mediastinum.
The mediastinal ROI on planar cardiac 123I-MIBG
images reflects nonspecific mediastinal tissue activity and
is a good reference site for the qualification of the cardiac
sympathetic innervation pattern, because of the small
amount of scatter and the low sympathetic activity in the
mediastinum [28]. Different sizes for the mediastinal ROI
have been reported, ranging from 7×7 pixels to 9×9 and
40 pixels with a 128×128 matrix, and from 13×13 pixels to
20×20 and 100 pixels with a 256 matrix [16]. However,
mostly the use of a rectangular mediastinal ROI has been
reported with unspecified size [16]. Since a rectangular
mediastinal ROI is recommended in the proposal for stan-
dardization by Flotats et al. [21], we chose to use a rectan-
gular mediastinal ROI with a size of 13×20 pixels (with a
256×256 matrix) placed in the upper part of the mediasti-
num. A standardized shape and size of the mediastinal ROI
is preferable, because small differences in size can cause
variations in the measured H/M ratio [17]. Furthermore, on
the determination of WR there is little consensus in the
literature. Over the different prognostic studies, more than
Fig. 4 Reliability of the WR on
planar MIBG images calculated
using method 1 (left panels)





agreement. The mean differences
(95 % limits of agreement) in the
intraobserver analysis were
−0.096 (−1.52 to 1.71) for
method 1 and −0.38 (−7.34 to
9.07) for method 2, in the
interobserver analysis were
−0.18 (−2.50 to 2.16) for method
1 and 0.87 (−10.10 to 10.14) for
method 2, in the experienced
versus inexperienced observer
analysis were −0.36 (−2.39 to
3.11) for method 1 and 2.38
(−11.50 to 16.26) for method 2,
respectively
Table 3 Intra- and interobserver agreement for patients with a low
delayed H/M ratio (≤1.4)
Analysis Delayed H/M
ratio
ICC for H/M ratio
(95 % CI)
Intraobserver
First measurement 1.28±0.11 0.93 (0.85–0.96)
Second measurement 1.30±0.10
Interobserver
First observer 1.25±0.11 0.93 (0.74–0.97)
Second observer 1.28±0.11
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six different methods are described for the calculation of the
WR from the early and delayed planar MIBG images [16].
In addition, the normal ranges and cut-off values for the WR
remain unclear, while the normal values are method-
dependent. Importantly, the discrepancies that arise from
the use of the different mathematical methods are clinically
relevant [16]. In the current analysis, the most reliable
results for the calculation of the WR in HF patients were
provided by calculation without background correction and
without the use of 123I time decay correction. Therefore, this
method might be the most appropriate for the calculation of
WR in HF patients.
Furthermore, for the assessment of the cardiac ROI in the
present study, a polygonal manually drawn cardiac ROI was
used including the myocardium and the left ventricular
cavity, which resulted in excellent intra- and interobserver
agreement of the early and delayed H/M ratios obtained.
However, a fixed-size cardiac ROI may be advantageous for
future development of standardized and automatically traced
cardiac ROIs. Therefore, we evaluated the reproducibility of
delayed H/M ratios using two types of fixed-size cardiac
ROIs. Both the oval and the circular fixed-size cardiac ROIs
showed excellent correlations with the manually drawn car-
diac ROI (ICC 0.95 and 0.86, respectively). However,
slightly more variation was observed when the circular
cardiac ROI was used. This variation could be explained
by the fact that the circular ROI covers only a part of the
heart. To prevent scatter from the lungs or liver, a circular
ROI with a radius of 21 pixels was chosen, fitting into the
apex of the myocardium without covering surrounding lung
or liver tissue. However, because in most HF patients the
left ventricle is enlarged, a circular cardiac ROI with a radius
of 21 pixels (approximately 30 mm) often covers only a
small part of the myocardium in these patients. This might
influence the accuracy of the measured delayed H/M ratios
in these patients. Okuda et al. used a cardiac ROI with a
Table 4 Agreement between the
delayed H/M ratios measured in
the manually drawn and fixed-
size cardiac ROIs




ICC for H/M ratio
(95 % CI)
Fixed-size oval 23.60±5.67 1.44±0.20 0.95 (0.93–0.97)
Manually drawn 23.52±5.64 1.43±0.20 0.86 (0.72–0.93)
Fixed-size circular 22.13±5.68 1.38±0.20
Fig. 5 Reliability of H/M ratios measured on delayed planar MIBG
images using fixed-size cardiac ROIs. Bland-Altman plots of the
differences between measured H/M ratios and the mean H/M ratios
(left), the mean average cardiac counts (centre), and the mean average
counts in the mediastinal ROI (right) using the manually drawn po-
lygonal cardiac ROI and the fixed-size cardiac ROIs. The mean
difference (95 % limits of agreement) between the measured H/M
ratios using the oval cardiac ROI (a, left) was −0.002 (−0.12 to
0.12), and using the circular cardiac ROI (b, left) was −0.063 (−0.30
to 0.17). This larger mean difference in mean H/M ratios was a result of
the wider spread and lower average counts in the cardiac ROI (b,
centre)
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radius of 30 mm in the development of a semiautomated
algorithm for the calculation of the H/M ratio, showing high
reproducibility (ICC 0.97 in the interobserver analysis of the
delayed H/M ratio) [19]. However, this study was performed
in 37 patients of whom only 5 had HF. For future develop-
ment of a semiautomated algorithm for the calculation of the
H/M ratio in HF patients, the use of a fixed oval cardiac ROI
is probably more suitable, because a larger amount of the
myocardium is covered using this method.
When routine clinical application of MIBG myocardial
scintigraphy is encouraged by the effort to standardize the
imaging procedure, knowledge about the acquired level of
experience needed to evaluate the images would be valu-
able. This study showed that the early and delayed H/M
ratios and WR measured by an inexperienced observer were
in excellent agreement with the measurements of an experi-
enced observer. A 2-h period of training examining five
example cases was enough for accurate setting of the medi-
astinal and cardiac ROI. This indicates that the data analysis
and the interpretation of planar MIBG images are feasible.
Therefore, MIBG myocardial scintigraphy could be imple-
mented easily in the clinical work-up of HF patients. More-
over, the subanalysis performed in patients with very low
delayed H/M ratios showed that the reliability remains
excellent over the total range of observed myocardial
sympathetic activity patterns detected on MIBG myocardial
scintigraphy in HF patients.
Limitations
The current study had several limitations. First, only the
reproducibility was evaluated in this study, while the
precision of planar MIBG myocardial scintigraphy also
depends on the validity of the measurements performed.
Second, the reproducibility of MIBG myocardial scintig-
raphy within subjects could not be evaluated, because
MIBG myocardial scintigraphy was not repeated in time
within the same patients. In the current study existing
data were used of one-time MIBG myocardial scintigra-
phy evaluations. For the within-subject reproducibility of
planar MIBG myocardial scintigraphy, a prospective
study with repeated MIBG myocardial scintigraphy over
time within the same patient is required. However, re-
peated MIBG myocardial scintigraphy within the same
patient would involve an increased radiation dose. Third,
we did not evaluate the influence of the size and location
of the mediastinal ROI on the measured H/M ratio.
However, the size of the mediastinal ROI was fixed
(13×20 pixels) and the location was specified so that
the variation in the mediastinal ROI was minimal in the
current analysis (as shown in the Bland-Altman plot in
Fig. 4). Still, an automatic method to set the mediastinal
ROI as “default” in order to correct any variation due to
the operator may be advisable. Fourth, analyses for the as-
sessment of regional myocardial sympathetic activity on
MIBG SPECT images were not performed in the current
study. Instead, this study focused mainly on measurements
on planar MIBG images. Further studies are needed to inves-
tigate the reliability of cardiac MIBG SPECT imaging.
Conclusion
The present study showed excellent reproducibility of pla-
nar MIBG myocardial scintigraphy in HF patients. More-
over, for the calculation of WR, the formula without
background correction showed high reliability and might
therefore be preferable in HF patients. Furthermore, we
observed only a small influence of the level of experience
on the assessment of H/M ratios and WR, indicating that the
data analysis and interpretation of planar MIBG images is
feasible. In addition, the use of a fixed-size oval cardiac ROI
could make the image analysis procedure even more stan-
dardized. Consequently, these results could contribute to the
standardization of the data analysis and interpretation of
planar MIBG images and therefore might provide extra
validation for the reliability of planar MIBG myocardial
scintigraphy in HF patients.
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